Beta 2-adrenergic receptor agonists are novel regulators of macrophage activation in diabetic renal and cardiovascular complications
Hyunjin Noh(Joslin Diabetes Center), George L. King(Joslin Diabetes Center), I‐Hsien Wu(Joslin Diabetes Center), Mi Ra Yu(Pusan National University), Ji Hye Lee, Hyun Joo Kim(Chonnam National University), Motonobu Matsumoto(Joslin Diabetes Center), Byoung‐Won Park(Soonchunhyang University)
Cited by 87
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
|Circulation Research|2010|979